Targeted therapies for pancreatic cancer
10.3760/cma.j.issn.1673-422X.2011.02.022
- VernacularTitle:胰腺癌的靶向治疗
- Author:
Feiying GU
;
Ying YUAN
- Publication Type:Journal Article
- Keywords:
Pancreatic neoplasms;
Protein-tyrosine kinases;
Monoclonal antibodies
- From:
Journal of International Oncology
2011;38(2):148-151
- CountryChina
- Language:Chinese
-
Abstract:
The combination of chemotherapy, radiotherapy and targeted therapies are considered to be major treatments for metastatic pancreatic cancer. At present, the target therapy-related medications include mainly antagonist of epidermal growth factor receptor, monoclonal antibody of vascular endothelial growth factor and so on. Erlotinib combined with gemcitabine has been demonstrated to prolong the survival of patients with pancreatic cancer.
